Clark Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.3K Buy
53
+22
+71% +$8.77K 0.01% 181
2026
Q2
$11.2K Buy
31
+4
+15% +$1.37K 0.01% 216
2026
Q1
$9.5K Hold
27
– – 0.01% 252
2025
Q4
$8.84K Hold
27
– – 0.01% 254
2025
Q3
$8.84K Hold
27
– – 0.01% 254
2025
Q2
$7.54K Hold
27
– – 0.01% 238
2025
Q1
$8.41K Hold
27
– – 0.01% 212
2024
Q4
$7.04K Buy
+27
New +$8.01K 0.01% 203

Other funds holding AMGN

Clark Wealth Partners's AMGN Position: Q3 2026 in Review

Clark Wealth Partners increased its Amgen (AMGN) stake by 71% in Q3 2026, buying an estimated $8.77K and bringing the position to 53 shares worth $22.3K. The position accounts for 0.01% of the portfolio, ranked #181.

Clark Wealth Partners first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Clark Wealth Partners held 53 shares of Amgen worth $22.3K as of Q3 2026.
  • Clark Wealth Partners bought 22 Amgen shares in Q3 2026, an estimated $8.77K.
  • Amgen made up 0.01% of Clark Wealth Partners's portfolio in Q3 2026, its #181 holding.
  • Clark Wealth Partners first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.